DCB0129

DCB0129 clinical safety roadmap — explained.

DCB0129 is the UK clinical risk management standard used for clinical risk management in UK health IT. This page explains what DCB0129 requires of a triage platform, what evidence healthcare buyers should ask for, and how TriageNix is developing a clinical safety case.
  • Clinical safety case in development
  • Hazard identification and risk review planned
  • Clinical Safety Officer review planned
  • Buyer-side DCB0160 considerations
  • Evidence pack planned for future evaluation
Planned
Clinical safety review
Not assessed
Hazard status
TBD
Evidence pack availability

What it is

DCB0129 is a UK standard for clinical risk management in health software. TriageNix is developing a clinical safety case, and a completed evidence pack is not yet available.

Who it's for

  • NHS information governance, clinical safety and IT teams evaluating suppliers
  • ICB digital transformation leads
  • Practice managers and GP IT leads
  • Procurement and DSPT assessors

How it works

    Step 1
    Hazard identification

    Clinical and engineering review planned for future releases.

    Step 2
    Risk scoring

    Risk scoring and mitigation documentation planned.

    Step 3
    CSO sign-off

    Clinical safety review is planned before deployment.

    Step 4
    Post-market surveillance

    Post-market surveillance to be established before deployment.

FAQ

What is DCB0129?

DCB0129 is a UK clinical risk management standard for health IT manufacturers. TriageNix is developing a clinical safety case in line with it.

Is DCB0129 mandatory?

UK healthcare buyers should assess the applicable clinical safety obligations before deployment. TriageNix has not completed its safety case.

What evidence does TriageNix provide?

A completed DCB0129 evidence pack is not yet available. Clinical safety work is in development.

Who oversees clinical safety?

A designated Clinical Safety Officer oversees development of the clinical safety case.

What is the DTAC and MHRA status?

MHRA registration, UKCA/CE marking, DTAC and DSPT have not been completed.

Request the DCB0129 evidence pack

The clinical safety case is in development; a completed evidence pack is not yet available.

Related